drugset / Trial / NCT02513563
AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to find out what effects (good and bad) AZD1775 used in combination with carboplatin and paclitaxel will have on participants and their cancer.
Timeline
- Start
- 2015-10-13
- Primary completion
- 2022-11-27
- Completion
- 2023-11-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adavosertib | Small molecule | 225 mg | — |
| Background | Carboplatin | Small molecule | — | — |
| Background | Paclitaxel | Small molecule | 175 mg/m2 | — |